XRCC1 Gene Polymorphism for Prediction of Response and Prognosis in the Multimodality Therapy of Patients with Locally Advanced Rectal Cancer

« Previous Next »Journal of Surgical Research
Volume 164, Issue 1 , Pages e61-e66, November 2010

Peter P. Grimminger, M.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Jan Brabender, M.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Ute Warnecke-Eberz, Ph.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Kosuke Narumiya, M.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Christoph Wandhöfer, M.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Uta Drebber, M.D.
- Department of Pathology, University of Cologne, Cologne, Germany
Elfriede Bollschweiler, M.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Arnulf H. Hölscher, M.D., F.R.C.S., F.A.C.S.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Ralf Metzger, M.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
Daniel Vallböhmer, M.D.
- Department of General, Visceral, and Cancer Surgery, University of Cologne, Cologne, Germany
- To whom correspondence and reprint requests should be addressed at Department of General, Visceral, and Cancer Surgery, University of Cologne, Kerpenerstrasse 62, 50937 Cologne, Germany.